| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.24 | 0.0005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.25 | 0.0001 |